Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158907 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2163660 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2163401 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL16431159 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL548514 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL548521 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL1240474 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL158906 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL9696115 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL415112 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 654 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116869844-A | Sun cream and preparation method thereof | 福州萍晴日用化妆品有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-114931522-B | Emulsion containing undecylenoyl phenylalanine and preparation method thereof | 江南大学 | 2023-05-23 | — | — | CN | claimed |
| CN-115463046-A | Bacteriostatic hand sanitizer easy to wash and preparation method thereof | 广州卓锐生物医药科技有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-114350089-A | Functionalized chlorinated polyvinyl chloride resin and preparation method and application thereof | 上海氯碱化工股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114292371-A | Preparation method of fluorescent reversible photoswitch nanoparticles and product thereof | 湖南科技大学 | 2022-04-08 | — | — | CN | claimed |
| EP-2782549-B1 | ANTIMICROBIAL PRESERVATIVE COMPOSITIONS FOR PERSONAL CARE PRODUCTS | GALAXY SURFACTANTS LTD (IN) | 2020-08-26 | — | — | EP | claimed |
| EP-2987799-B1 | ESTER DERIVATIVE OF 7-ALPHA-[9-(4,4,5,5,5-PENTAFLUOROPENTYLSULPHINYL)NONYL]OESTRA-1,3,5(10)-TRIENE-3,17BETA-DIOL HAVING ANTITUMOUR ACTIVITY AND PREPARATION METHOD THEREOF | XIAN LIBANG PHARMACEUTICAL TECH CO LTD (CN) | 2020-04-08 | — | — | EP | claimed |
| CN-110225743-A | Microemulsion compositions comprising polydatin and methods of use | 莱雅公司 | 2019-09-10 | — | — | CN | claimed |
| EP-2987492-B1 | USE OF 7-A-[9-(4,4,5,5,5 - PENTAFLUORO-PENTYL-SULFINYL)NONYL]-ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL AND DERIVATIVES THEREOF | XIAN LIBANG PHARMACEUTICAL TECH CO LTD (CN) | 2019-05-01 | — | — | EP | claimed |
| US-20190099342-A1 | COOLING PRODUCT | SYMRISE AG (DE) | 2019-04-04 | — | — | US | claimed |
| US-20050118119-A1 | Use of a compound inactivating the kinase a protein in a composition containg a cosmetically acceptable medium in order to lighten the skin | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) | 2005-06-02 | — | — | US | claimed |
| EP-1061895-B1 | SYNERGETIC COMPOSITION COMPRISING A COMPOUND WITH LIPOAMINOACID STRUCTURE AND A TUBEROUS WATER-LILY EXTRACT | SEPPIC SA (FR) | 2003-04-23 | — | — | EP | claimed |
| US-20020032243-A1 | Novel inverse latices self-invertible with respect to fatty acid esters, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising them | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC | 2002-03-14 | — | — | US | claimed |
| US-20020006906-A1 | Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES | 2002-01-17 | — | — | US | claimed |
| EP-0972512-B1 | Cosmetic composition containing pigments, an antiperspirant and a solid elastomeric partially crosslinked organopolysiloxane, use of such a composition | OREAL (FR) | 2002-01-02 | — | — | EP | claimed |
| US-20010002257-A1 | Composition comprising a lipoamino acid and the constituents of a tannin-rich plant extract, and cosmetic use thereof | STOLZ CORINNE (FR) | 2001-05-31 | — | — | US | claimed |
| US-6123758-A | FOR USE IN INK JET PRINTING | XEROX CORPORATION (US) | 2000-09-26 | — | — | US | claimed |
| EP-0972512-A1 | Cosmetic composition containing pigments, an antiperspirant and a solid elastomeric partially crosslinked organopolysiloxane, use of such a composition | L'OREAL (FR) | 2000-01-19 | — | — | EP | claimed |
| EP-0972509-A1 | Cosmetic composition containing pigments and antiperspirant agents, use of such a composition | L'OREAL (FR) | 2000-01-19 | — | — | EP | claimed |
| EP-0593506-B1 | LIPOAMINOACIDS, PREPARATION METHOD AND APPLICATIONS | GIVAUDAN LAVIROTTE (FR) | 1996-03-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | TRPA1, TRPV2, NISCH | FAAH 53/4885TRPV1 4/4885TSHR 2965/4885 |
| US-20020006906-A1 | Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports | CUTA, PLOD3, SOST | FAAH 907/4885TRPV1 203/4885TSHR 4715/4885 |
| US-20010002257-A1 | Composition comprising a lipoamino acid and the constituents of a tannin-rich plant extract, and cosmetic use thereof | LIPC, PLIN1, LRAT | FAAH 33/4885TRPV1 1068/4885TSHR 2099/4885 |
| US-20050118119-A1 | Use of a compound inactivating the kinase a protein in a composition containg a cosmetically acceptable medium in order to lighten the skin | PRKACG, PRKACA, PRKACB | FAAH 3012/4885TRPV1 3208/4885TSHR 4205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.